FDA Consumer Magazine -- June 1994
Table of Contents

Getting Lyme Disease to Take a Hike
Before you heard for the wilds this summer, you may want to find out how to prevent a disease spread by tick bite whose symptoms are similar to arthritis.

Quake, Flood Call for FDA Action
The Northridge, Calif., earthquake and the last year's Midwest flooding are two of the biggest natural disasters requiring FDA to make sure that the products it regulates remain fit to use.

Multiple Sclerosis New Treatment Reduces Relapses
A biologic product brought to market under FDA's accelerated approval regulations is the first treatment licensed specifically to treat multiple sclerosis, which affects approximately 300,000 Americans, most between the ages of 20 and 40.

Orphan Products: New Hope for People with Rare Disorders
People with hemophilia, certain leukemias, cystic fibrosis, and AIDS-related conditions are among those benefiting from FDA's Orphan Products Program, which has helped get more than 100 products for rare diseases on the market since it began in 1983.

Striking Back at Stroke
Lifestyle changes and drug treatments have helped lower the percentage of persons stricken by stroke over the last 50 years. Still, stroke disables 200,000 Americans a year and kills 150,000. New drugs--and new ways of using old ones--offer hope for more progress.

(Hypertext updated by clb March 17, 1998)